Pancreatic Cancer Clinical Trials

Showing 941-960 of 1,185 trials

EUS BD vs ERCP TP for Pancreatic Cancer

NCT03063554

This Endoscopic Ultrasound guided Biliary Drainage (EUS-BD) vs. Endoscopic Retrograde Cholangiopancreatography (ERCP-TP) trial (BILPAL) is a randomized controlled multicenter trial that will provide evidence whether or not traditional ERCP biliary drainage is to be performed in patients with obstruction in bile duct due to unresectable pancreatic head or periampullary tumor.

Pancreatic CancerPancreatic AdenocarcinomaBiliary Tract Neoplasms+4 more

Weill Medical College of Cornell University120 participantsStarted Oct 2016

New York, New York, United States

COMPLETEDPhase 1

Gem-TABS in Unresectable Pancreatic Carcinoma

NCT01198821

The purpose of this study is to: Find out the largest dose of sodium bicarbonate that can be given with gemcitabine. Determine if the combination of sodium bicarbonate and gemcitabine produces better control of pancreatic cancer than gemcitabine alone.

Pancreatic Cancer

H. Lee Moffitt Cancer Center and Research Institute8 participantsStarted Aug 2010

Tampa, Florida, United States

UNKNOWNNA

Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

NCT01771146

A prospective evaluation of neoadjuvant FOLFIRINOX regimen in patients with non-metastatic pancreas cancer (Baylor University Medical Center and Texas Oncology Experience)

Pancreas CancerLocalized Pancreas CancerNon-metastatic Pancreas Cancer

Baylor Research Institute30 participantsStarted Oct 2012

Dallas, Texas, United States

EUS BD vs ERCP TP for Pancreatic Cancer

Gem-TABS in Unresectable Pancreatic Carcinoma

Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

Related Searches

Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

Translational Research on Locally Advanced Pancreatic Adenocarcinoma

Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas

Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy

Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer

A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy

A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer

Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)

Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer